Bartlett & Co Wealth Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8
Closed -$1.91K 460
2021
Q3
$1.91K Buy
+8
New +$2.29K ﹤0.01% 875

Other funds holding BLUE

Bartlett & Co Wealth Management's BLUE Position: Q4 2021 in Review

Bartlett & Co Wealth Management sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 8 shares — an estimated $1.91K sold.

Bartlett & Co Wealth Management first reported a position in BLUE in Q3 2021 and held it in 1 quarter. The position peaked at $1.91K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Bartlett & Co Wealth Management reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 8 bluebird bio shares in Q4 2021, an estimated $1.91K.
  • Bartlett & Co Wealth Management first reported a position in bluebird bio in Q3 2021 and held it in 1 quarter.
  • Bartlett & Co Wealth Management's bluebird bio position peaked at $1.91K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Bartlett & Co Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2024.